Enterome

0 followers


Enterome’s OncoMimic technology allows the overcoming of immune tolerance against cancer cells, with broad applicability against solid tumor via an off-the-shelf, easy to manufacture technology. Enterome’s potentially first-in-class small protein and peptide drug candidates modulate the immune syste... Read more

Headquarters

Paris, FR

Employees

51-200

Links

Org chart

Belichard Pierre

Collapse
Christelle Dumoussaud
Chief Financial Officer
Jan Fagerberg
Chief Medical Officer
Jean-Michel Paillarse
Chief Medical Officer
Joel Richard, PhD, HDR
Chief Development Officer, Executive Committee Member
Marie-Laure Bouttier
Chief Corporate Officer
Pierre Sahakian
Head Of Regulatory Affairs
Joao G. Magalhaes
Head of Immunology research
Lucie Rouch
Chief Clinical Operations Officer